Correction: Everolimus (Eve) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: New lessons for clinical practice from the EVA study (Oncotarget (2018) 9:77 (34639-34640) DOI: 10.18632/oncotarget.25874)

Marina Cazzaniga; Claudio Verusio; Mariangela Ciccarese; Alberto Fumagalli; Donata Sartori; Chiara Ancona; Mario Airoldi; Gabriella Moretti; Corrado Ficorella; Valentina Arcangeli; Lucrezia Diodati; Alberto Zambelli; Antonio Febbraro; Daniele Generali; Mirco Pistelli; Ornella Garrone; Antonino Musolino; Patrizia Vici; Michela Maur; Lucia Mentuccia; Nicla La Verde; Giulia Bianchi; Salvatore Artale; Livio Blasi; Michela Piezzo; Francesco Atzori; Anna Turletti; Chiara Benedetto; Maria Concetta Cursano; Alessandra Fabi; Vittorio Gebbia; Antonio Schirone; Raffaella Palumbo; Antonella Ferzi; Antonio Frassoldati; Claudio Scavelli; Luca Clivio

doi:10.18632/oncotarget.26213

Correction: Everolimus (Eve) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: New lessons for clinical practice from the EVA study (Oncotarget (2018) 9:77 (34639-34640) DOI: 10.18632/oncotarget.25874)

Marina Cazzaniga, Claudio Verusio, Mariangela Ciccarese, Alberto Fumagalli, Donata Sartori, Chiara Ancona, Mario Airoldi, Gabriella Moretti, Corrado Ficorella, Valentina Arcangeli, Lucrezia Diodati, Alberto Zambelli, Antonio Febbraro, Daniele Generali, Mirco Pistelli, Ornella Garrone, Antonino Musolino, Patrizia Vici, Michela Maur, Lucia MentucciaNicla La Verde, Giulia Bianchi, Salvatore Artale, Livio Blasi, Michela Piezzo, Francesco Atzori, Anna Turletti, Chiara Benedetto, Maria Concetta Cursano, Alessandra Fabi, Vittorio Gebbia, Antonio Schirone, Raffaella Palumbo, Antonella Ferzi, Antonio Frassoldati, Claudio Scavelli, Luca Clivio

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

Original language	English
Pages (from-to)	34639-34640
Number of pages	2
Journal	Oncotarget
Volume	9
Issue number	77
DOIs	https://doi.org/10.18632/oncotarget.26213
Publication status	Published - Aug 1 2018

Access to Document

10.18632/oncotarget.26213

Fingerprint

Dive into the research topics of 'Correction: Everolimus (Eve) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: New lessons for clinical practice from the EVA study (Oncotarget (2018) 9:77 (34639-34640) DOI: 10.18632/oncotarget.25874)'. Together they form a unique fingerprint.

Cite this

Cazzaniga, M., Verusio, C., Ciccarese, M., Fumagalli, A., Sartori, D., Ancona, C., Airoldi, M., Moretti, G., Ficorella, C., Arcangeli, V., Diodati, L., Zambelli, A., Febbraro, A., Generali, D., Pistelli, M., Garrone, O., Musolino, A., Vici, P., Maur, M., ... Clivio, L. (2018). Correction: Everolimus (Eve) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: New lessons for clinical practice from the EVA study (Oncotarget (2018) 9:77 (34639-34640) DOI: 10.18632/oncotarget.25874). Oncotarget, 9(77), 34639-34640. https://doi.org/10.18632/oncotarget.26213

Correction: Everolimus (Eve) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: New lessons for clinical practice from the EVA study (Oncotarget (2018) 9:77 (34639-34640) DOI: 10.18632/oncotarget.25874). / Cazzaniga, Marina; Verusio, Claudio; Ciccarese, Mariangela; Fumagalli, Alberto; Sartori, Donata; Ancona, Chiara; Airoldi, Mario; Moretti, Gabriella; Ficorella, Corrado; Arcangeli, Valentina; Diodati, Lucrezia; Zambelli, Alberto; Febbraro, Antonio; Generali, Daniele; Pistelli, Mirco; Garrone, Ornella; Musolino, Antonino; Vici, Patrizia; Maur, Michela; Mentuccia, Lucia; La Verde, Nicla; Bianchi, Giulia; Artale, Salvatore; Blasi, Livio; Piezzo, Michela; Atzori, Francesco; Turletti, Anna; Benedetto, Chiara; Cursano, Maria Concetta; Fabi, Alessandra; Gebbia, Vittorio; Schirone, Antonio; Palumbo, Raffaella; Ferzi, Antonella; Frassoldati, Antonio; Scavelli, Claudio; Clivio, Luca.

In: Oncotarget, Vol. 9, No. 77, 01.08.2018, p. 34639-34640.

Research output: Contribution to journal › Comment/debate › peer-review

Cazzaniga, M, Verusio, C, Ciccarese, M, Fumagalli, A, Sartori, D, Ancona, C, Airoldi, M, Moretti, G, Ficorella, C, Arcangeli, V, Diodati, L, Zambelli, A, Febbraro, A, Generali, D, Pistelli, M, Garrone, O, Musolino, A, Vici, P, Maur, M, Mentuccia, L, La Verde, N, Bianchi, G, Artale, S, Blasi, L, Piezzo, M, Atzori, F, Turletti, A, Benedetto, C, Cursano, MC, Fabi, A, Gebbia, V, Schirone, A, Palumbo, R, Ferzi, A, Frassoldati, A, Scavelli, C & Clivio, L 2018, 'Correction: Everolimus (Eve) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: New lessons for clinical practice from the EVA study (Oncotarget (2018) 9:77 (34639-34640) DOI: 10.18632/oncotarget.25874)', Oncotarget, vol. 9, no. 77, pp. 34639-34640. https://doi.org/10.18632/oncotarget.26213

Cazzaniga M, Verusio C, Ciccarese M, Fumagalli A, Sartori D, Ancona C et al. Correction: Everolimus (Eve) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: New lessons for clinical practice from the EVA study (Oncotarget (2018) 9:77 (34639-34640) DOI: 10.18632/oncotarget.25874). Oncotarget. 2018 Aug 1;9(77):34639-34640. https://doi.org/10.18632/oncotarget.26213

Cazzaniga, Marina ; Verusio, Claudio ; Ciccarese, Mariangela ; Fumagalli, Alberto ; Sartori, Donata ; Ancona, Chiara ; Airoldi, Mario ; Moretti, Gabriella ; Ficorella, Corrado ; Arcangeli, Valentina ; Diodati, Lucrezia ; Zambelli, Alberto ; Febbraro, Antonio ; Generali, Daniele ; Pistelli, Mirco ; Garrone, Ornella ; Musolino, Antonino ; Vici, Patrizia ; Maur, Michela ; Mentuccia, Lucia ; La Verde, Nicla ; Bianchi, Giulia ; Artale, Salvatore ; Blasi, Livio ; Piezzo, Michela ; Atzori, Francesco ; Turletti, Anna ; Benedetto, Chiara ; Cursano, Maria Concetta ; Fabi, Alessandra ; Gebbia, Vittorio ; Schirone, Antonio ; Palumbo, Raffaella ; Ferzi, Antonella ; Frassoldati, Antonio ; Scavelli, Claudio ; Clivio, Luca. / Correction: Everolimus (Eve) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: New lessons for clinical practice from the EVA study (Oncotarget (2018) 9:77 (34639-34640) DOI: 10.18632/oncotarget.25874). In: Oncotarget. 2018 ; Vol. 9, No. 77. pp. 34639-34640.

@article{4bd664d4031d49b5915f7c5a897395c2,

title = "Correction: Everolimus (Eve) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: New lessons for clinical practice from the EVA study (Oncotarget (2018) 9:77 (34639-34640) DOI: 10.18632/oncotarget.25874)",

author = "Marina Cazzaniga and Claudio Verusio and Mariangela Ciccarese and Alberto Fumagalli and Donata Sartori and Chiara Ancona and Mario Airoldi and Gabriella Moretti and Corrado Ficorella and Valentina Arcangeli and Lucrezia Diodati and Alberto Zambelli and Antonio Febbraro and Daniele Generali and Mirco Pistelli and Ornella Garrone and Antonino Musolino and Patrizia Vici and Michela Maur and Lucia Mentuccia and {La Verde}, Nicla and Giulia Bianchi and Salvatore Artale and Livio Blasi and Michela Piezzo and Francesco Atzori and Anna Turletti and Chiara Benedetto and Cursano, {Maria Concetta} and Alessandra Fabi and Vittorio Gebbia and Antonio Schirone and Raffaella Palumbo and Antonella Ferzi and Antonio Frassoldati and Claudio Scavelli and Luca Clivio",

year = "2018",

month = aug,

day = "1",

doi = "10.18632/oncotarget.26213",

language = "English",

volume = "9",

pages = "34639--34640",

journal = "Oncotarget",

issn = "1949-2553",

publisher = "Impact Journals LLC",

number = "77",

}

TY - JOUR

T1 - Correction: Everolimus (Eve) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: New lessons for clinical practice from the EVA study (Oncotarget (2018) 9:77 (34639-34640) DOI: 10.18632/oncotarget.25874)

AU - Cazzaniga, Marina

AU - Verusio, Claudio

AU - Ciccarese, Mariangela

AU - Fumagalli, Alberto

AU - Sartori, Donata

AU - Ancona, Chiara

AU - Airoldi, Mario

AU - Moretti, Gabriella

AU - Ficorella, Corrado

AU - Arcangeli, Valentina

AU - Diodati, Lucrezia

AU - Zambelli, Alberto

AU - Febbraro, Antonio

AU - Generali, Daniele

AU - Pistelli, Mirco

AU - Garrone, Ornella

AU - Musolino, Antonino

AU - Vici, Patrizia

AU - Maur, Michela

AU - Mentuccia, Lucia

AU - La Verde, Nicla

AU - Bianchi, Giulia

AU - Artale, Salvatore

AU - Blasi, Livio

AU - Piezzo, Michela

AU - Atzori, Francesco

AU - Turletti, Anna

AU - Benedetto, Chiara

AU - Cursano, Maria Concetta

AU - Fabi, Alessandra

AU - Gebbia, Vittorio

AU - Schirone, Antonio

AU - Palumbo, Raffaella

AU - Ferzi, Antonella

AU - Frassoldati, Antonio

AU - Scavelli, Claudio

AU - Clivio, Luca

PY - 2018/8/1

Y1 - 2018/8/1

UR - http://www.scopus.com/inward/record.url?scp=85054264901&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054264901&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.26213

DO - 10.18632/oncotarget.26213

M3 - Comment/debate

AN - SCOPUS:85054264901

VL - 9

SP - 34639

EP - 34640

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 77

ER -

Correction: Everolimus (Eve) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: New lessons for clinical practice from the EVA study (Oncotarget (2018) 9:77 (34639-34640) DOI: 10.18632/oncotarget.25874)

Abstract

Access to Document

Other files and links

Fingerprint

Cite this